Community Clinical Oncology Program

The summary for the Community Clinical Oncology Program grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Community Clinical Oncology Program: The Division of Cancer Prevention (DCP), National Cancer Institute (NCI), invites domestic institutions to apply for cooperative agreements in response to this Community Clinical Oncology Program (CCOP) Request for Applications (RFA). Applicants for new and currently funded Community Clinical Oncology Programs (CCOP) and research bases (cooperative groups and cancer centers that design the protocols for clinical trials, collect and analyze study data, and monitor the data quality and patient accrual performance of CCOPs and other institutional members) are invited to respond to this RFA. Using the national resource of highly trained oncologists in community practice, the CCOP: 1) provides support for expanding the clinical research effort in the community setting; 2) stimulates quality care in the community through participation in protocol studies; 3) fosters the growth and development of a scientifically viable community cancer network able to work closely with NCI-supported clinical cooperative groups and cancer centers; 4) supports development of and community participation in cancer prevention and control intervention research, which includes chemoprevention, biomarkers, early detection, symptom management, quality of life, rehabilitation, and continuing care research; 5) involves primary care providers and other specialists in cancer prevention and control clinical trials; and 6) increases the involvement of minority and underserved populations in clinical research. Combining the efforts and expertise of community physicians and other health care professionals with those of the NCI-funded cancer treatment and prevention and control clinical trials groups provides opportunities for transfers of the latest research findings to the community level. The NCI-supported clinical cooperative groups and/or cancer centers serve as research bases for the CCOPs. These research bases design the protocols for the clinical trials in cancer treatment, prevention, and early detection as well as evaluating interventions affecting quality of life, rehabilitation, and symptom management associated with cancer and its treatment. In addition, research bases manage and analyze all data collected and monitor data quality and subject accrual. The research bases seek to define the key unanswered questions in cancer and then conduct clinical trials to answer these questions. This reissuance of the CCOP RFA seeks to build on the strength and demonstrated success of the CCOP network over the past 20 years by: 1) continuing the program as a vehicle for supporting community participation in cancer treatment and prevention and control clinical trials through research bases (clinical cooperative groups and cancer centers supported by NCI); 2) expanding and strengthening the cancer prevention and control research effort; 3) utilizing the CCOP network for conducting NCI-assisted cancer prevention and control research; and 4) evaluating on a continuing basis CCOP performance and its impact in the community.